Cue Biopharma, Inc.CUENASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank70
3Y CAGR-0.7%
5Y CAGR+2.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-0.7%/yr
vs +7.8%/yr prior
5Y CAGR
+2.4%/yr
Recent deceleration
Acceleration
-8.5pp
Decelerating
Percentile
P70
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$37.74M+4.0%
2024$36.30M-11.0%
2023$40.80M+5.8%
2022$38.58M-6.7%
2021$41.35M+23.3%
2020$33.55M+22.0%
2019$27.49M-3.7%
2018$28.54M+51.0%
2017$18.90M+232.3%
2016$5.69M-